Joshua Reed
CIK 1746541 · SVP, Chief Financial Officer · last filed 2026-10-09
Joshua Reed is a SVP, Chief Financial Officer who has filed 24 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for ALKS, was dated Oct 9, 2026. Across all open-market trades the lifetime net is −$309.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SRRK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
131 HARTWELL AVENUE, SUITE 320
LEXINGTON, MA 02421
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALKS | SVP, Chief Financial Officer | 5,095 | $45.53 | $232.0K | $0 | 3 | 2026-10-09 |
| SRRK | Director | 20,466 | $46.95 | $960.9K | -$324.5K | 8 | 2026-07-06 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Chief Financial Officer | — | $0.14 | — | $0 | 4 | 2024-02-09 |
| ALDX | Chief Financial Officer | 274,825 | $0.63 | $173.5K | $15.1K | 7 | 2022-04-01 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-09 | ALKS | Mixed | +5,095 | -$163.2K | EDGAR |
| 2026-07-06 | SRRK | Sell (S) | −3,053 | -$164.1K | EDGAR |
| 2026-07-01 | SRRK | Notice (144) | −3,053 | -$167.3K | EDGAR |
| 2026-06-08 | SRRK | Grant (A) | +6,839 | $0 | EDGAR |
| 2026-03-04 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2025-10-10 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | SRRK | Sell (S) | −5,400 | -$160.5K | EDGAR |
| 2025-05-29 | SRRK | Notice (144) | −5,400 | -$160.2K | EDGAR |
| 2025-05-23 | SRRK | Grant (A) | +7,632 | $0 | EDGAR |
| 2024-07-01 | SRRK | Grant (A) | +13,500 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.